Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124


Caveolin 1 protein expression in renal cell carcinoma predicts survival.

Steffens S, Schrader AJ, Blasig H, Vetter G, Eggers H, Tränkenschuh W, Kuczyk MA, Serth J.

BMC Urol. 2011 Dec 7;11:25. doi: 10.1186/1471-2490-11-25.


Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.

Waalkes S, Eggers H, Blasig H, Atschekzei F, Kramer MW, Hennenlotter J, Tränkenschuh W, Stenzl A, Serth J, Schrader AJ, Kuczyk MA, Merseburger AS.

Biomark Med. 2011 Apr;5(2):219-25. doi: 10.2217/bmm.11.12.


High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.

Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J.

BJU Int. 2012 May;109(10):1565-70. doi: 10.1111/j.1464-410X.2011.10649.x. Epub 2011 Oct 7.


Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.


Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.


Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis.

Mignogna C, Staibano S, Altieri V, De Rosa G, Pannone G, Santoro A, Zamparese R, D'Armiento M, Rocchetti R, Mezza E, Nasti M, Strazzullo V, Montanaro V, Mascolo M, Bufo P.

BMC Cancer. 2006 Dec 19;6:293.


Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.

Steffens S, Köhler A, Rudolph R, Eggers H, Seidel C, Janssen M, Wegener G, Schrader M, Kuczyk MA, Schrader AJ.

BMC Cancer. 2012 Sep 8;12:399. doi: 10.1186/1471-2407-12-399.


Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.

Bedke J, Chun FK, Merseburger A, Scharpf M, Kasprzyk K, Schilling D, Sievert KD, Stenzl A, Kruck S.

BJU Int. 2012 Dec;110(11 Pt B):E771-7. doi: 10.1111/j.1464-410X.2012.11642.x. Epub 2012 Nov 7.


Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.

Ronkainen H, Hirvikoski P, Kauppila S, Vaarala MH.

Oncol Rep. 2011 Jan;25(1):129-33.


Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.

Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M.

Oncol Rep. 2008 Sep;20(3):511-6.


Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).

de Martino M, Klatte T, Seemann C, Waldert M, Haitel A, Schatzl G, Remzi M, Weibl P.

BJU Int. 2013 Jun;111(8):E348-53. doi: 10.1111/bju.12067. Epub 2013 Mar 15.


Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.

Meyer HA, Tölle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G.

Eur Urol. 2009 Mar;55(3):669-78. doi: 10.1016/j.eururo.2008.04.001. Epub 2008 Apr 9.


Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.

Harada K, Miyake H, Kusuda Y, Fujisawa M.

BJU Int. 2012 Dec;110(11 Pt C):E1131-7. doi: 10.1111/j.1464-410X.2012.11297.x. Epub 2012 Jun 19.


Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.

Moon A, Park JY, Sung JY, Park YK, Kim YW.

Pathology. 2012 Oct;44(6):534-9.


High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients.

Pichler M, Hutterer GC, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R.

Br J Cancer. 2013 Sep 3;109(5):1123-9. doi: 10.1038/bjc.2013.443. Epub 2013 Aug 6.


Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.

Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.

Urology. 2007 May;69(5):843-8.


Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.

Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC.

Cancer. 2003 Mar 1;97(5):1225-33.

Supplemental Content

Support Center